Inhibitory effects of 17ß-estradiol or a resveratrol dimer on hypoxia-inducible factor-1a in genioglossus myoblasts: Involvement of ERa and its downstream p38 MAPK pathways

Abstract

Deficiency in the functioning of the genioglossus, which is one of the upper airway dilator muscles, is an important cause of obstructive sleep apnea/hypopnea syndrome (OSAHS). Estrogens have been reported to inhibit hypoxiainducible factor-1a (HIF-1a) expression in hypoxia, regulating its target genes and exerting protective effects on the genioglossus in chronic intermittent hypoxia (CIH). This study aimed to investigate the role of 17ß-estradiol (E2) and a resveratrol dimer (RD) on HIF-1a and the underlying mechanism. Mouse genioglossus myoblasts were isolated and cultured, and the estrogen receptor a (ERa) shRNA lentivirus was used for gene knockdown. Then MTT assay was used to determine the effects of E2 and RD on the viability of the cells. Cells in different groups were treated with different agents (E2, or RD, or E2 and SB203580), incubated under normoxia or hypoxia for 24 h, and then expression levels of HIF-1a, ERa, ERß, total-p38 MAPK and phospho-p38 MAPK were detected. We observed that both E2 and RD inhibited the overexpression of HIF-1a induced by hypoxia at the mRNA and protein levels, and these effects were eliminated by genetic silencing of ERa by RNAi. In addition, we found that E2 activated p38 MAPK pathways to inhibit HIF-1a expression. On the whole, ERa may be responsible for downregulation of HIF-1a by E2 or RD via activation of downstream p38 MAPK pathways.